Menu Back toSession 7: Academia’s Challenges in Clinical Trial Disclosure – Bridging the Gap

Clinical Trial Disclosure & Data Transparency Conference

Evolving Requirements and New Challenges


Session 7: Academia’s Challenges in Clinical Trial Disclosure – Bridging the Gap

Session Chair(s)

Robert  Paarlberg, MS

Robert Paarlberg, MS

  • Principal
  • Paarlberg & Associates LLC, United States

This session will focus on the challenges by academia in the EU and US in complying with clinical trial disclosure requirements. It will address the following topics:

  • Experience with a European peer-to-peer network of non-commercial clinical trial registry managers
  • Allocating resources for disclosure related activities
  • Organizational impact as a consequence of the Clinical Trials Information System
  • US academic task force

Speaker(s)

Britta  Lang

Experience with a European Peer-To-Peer Network of Non-Commercial Clinical Trial Registry Managers

Britta Lang

  • Head of Board
  • KKS- Network, Germany
Andrea  Seidel-Glaetzer, MA, RN

Organisational Impact as a Consequence of the Clinical Trials Information System

Andrea Seidel-Glaetzer, MA, RN

  • Head of Project Management and Member of the Executive Board
  • Coordination Centre For Clinical Trials Heidelberg (KKS), Germany
Erin  McDonagh

Academia Challenges in Clinical Trial Disclosure

Erin McDonagh

  • Regulatory Facilitator
  • University of Colorado Anschutz, United States

Contact us


Registration Questions?

Send Email
+41 61 225 51 51


Pre-conference Workshop

Workshop: Practical Implications of CTIS